Palaia, I.; Caruso, G.; Di Donato, V.; Vestri, A.; Napoli, A.; Perniola, G.; Casinelli, M.; Alunni Fegatelli, D.; Campagna, R.; Tomao, F.;
et al. Pfizer-BioNTech COVID-19 Vaccine in Gynecologic Oncology Patients: A Prospective Cohort Study. Vaccines 2022, 10, 12.
https://doi.org/10.3390/vaccines10010012
AMA Style
Palaia I, Caruso G, Di Donato V, Vestri A, Napoli A, Perniola G, Casinelli M, Alunni Fegatelli D, Campagna R, Tomao F,
et al. Pfizer-BioNTech COVID-19 Vaccine in Gynecologic Oncology Patients: A Prospective Cohort Study. Vaccines. 2022; 10(1):12.
https://doi.org/10.3390/vaccines10010012
Chicago/Turabian Style
Palaia, Innocenza, Giuseppe Caruso, Violante Di Donato, Annarita Vestri, Anna Napoli, Giorgia Perniola, Matteo Casinelli, Danilo Alunni Fegatelli, Roberta Campagna, Federica Tomao,
and et al. 2022. "Pfizer-BioNTech COVID-19 Vaccine in Gynecologic Oncology Patients: A Prospective Cohort Study" Vaccines 10, no. 1: 12.
https://doi.org/10.3390/vaccines10010012
APA Style
Palaia, I., Caruso, G., Di Donato, V., Vestri, A., Napoli, A., Perniola, G., Casinelli, M., Alunni Fegatelli, D., Campagna, R., Tomao, F., D’Aniello, D., Antonelli, G., & Muzii, L.
(2022). Pfizer-BioNTech COVID-19 Vaccine in Gynecologic Oncology Patients: A Prospective Cohort Study. Vaccines, 10(1), 12.
https://doi.org/10.3390/vaccines10010012
